PackGene Biotech

Houston, United States

PackGene Biotech provides CRO/CDMO services for gene therapy and cell therapy researchers and developers.

$14.1M raised

Dec 2023

Series C

Biotechnology Health Care

Top Investors

HSGCathay CapitalDecheng CapitalOriza HoldingsOriza Seed Capital (Oriza Yuandian)

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about PackGene Biotech

How much funding has PackGene Biotech raised?

PackGene Biotech has raised $14.1M in total funding. The most recent round was Series C. The last funding was announced in December 2023.

Who are PackGene Biotech's investors?

PackGene Biotech's investors include HSG, Cathay Capital, Decheng Capital, Oriza Holdings, Oriza Seed Capital (Oriza Yuandian).

Where is PackGene Biotech headquartered?

PackGene Biotech is headquartered in Houston, United States.

What does PackGene Biotech do?

PackGene Biotech provides CRO/CDMO services for gene therapy and cell therapy researchers and developers.

What stage is PackGene Biotech at?

PackGene Biotech is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 1, 2023.

MLA

"PackGene Biotech — Funding & Investors." VCBacked, December 1, 2023, https://www.vcbacked.co/company/packgene-biotech. Accessed June 4, 2026.

APA

VCBacked. (2023). PackGene Biotech — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/packgene-biotech

Wikipedia (cite web)

{{cite web |title=PackGene Biotech — Funding & Investors |url=https://www.vcbacked.co/company/packgene-biotech |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 1, 2023.

Similar Companies in Biotechnology